Ben Arye Barak 4
4 · NovoCure Ltd · Filed Mar 6, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Ben Arye Barak
General Counsel
Transactions
- Award
Ordinary Shares
2025-03-04$18.19/sh+54,975$999,995→ 173,696 total - Award
Stock Options (Right to buy)
2025-03-04$18.19/sh+81,499$1,482,467→ 81,499 totalExercise: $18.19From: 2026-03-04Exp: 2035-03-03→ Ordinary Shares (81,499 underlying)
Footnotes (2)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
- [F2]Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.